PriceTargets.com logo

Pebblebrook Hotel Trust - PEB Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $14.30
  • Forecasted Upside: 13.94%
  • Number of Analysts: 5
  • Breakdown:
  • 1 Sell Ratings
  • 3 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$12.55 As of 11/21/2024 10:48 AM ET
▲ +0.18 (1.46%)

This chart shows the closing price for PEB by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Pebblebrook Hotel Trust Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PEB and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PEB

Analyst Price Target is $14.30
▲ +13.94% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Pebblebrook Hotel Trust in the last 3 months. The average price target is $14.30, with a high forecast of $17.00 and a low forecast of $13.00. The average price target represents a 13.94% upside from the last price of $12.55.

This chart shows the closing price for PEB for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 5 contributing investment analysts is to hold stock in Pebblebrook Hotel Trust. This rating changed within the last month from a Reduce consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 6 hold ratings
  • 2 sell ratings
Ratings as of
5/30/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 6 hold ratings
  • 1 sell ratings
Ratings as of
8/28/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 8 hold ratings
  • 1 sell ratings
Ratings as of
11/26/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 2 sell ratings
Ratings as of
2/24/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 6 hold ratings
  • 2 sell ratings
Ratings as of
5/24/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 2 sell ratings
Ratings as of
8/22/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 2 sell ratings
Ratings as of
10/21/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 1 sell ratings
Ratings as of
11/20/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/21/2024Compass PointUpgradeNeutral ➝ Buy$17.00 ➝ $17.00
10/31/2024Robert W. BairdLower TargetNeutral ➝ Neutral$15.00 ➝ $14.00
10/28/2024Truist FinancialLower TargetHold ➝ Hold$15.00 ➝ $14.00
9/13/2024Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$15.00 ➝ $13.00
5/30/2024Truist FinancialLower TargetHold ➝ Hold$16.00 ➝ $15.00
3/28/2024Compass PointReiterated RatingBuy ➝ Neutral$17.00
1/18/2024Truist FinancialBoost TargetHold ➝ Hold$15.00 ➝ $16.00
1/8/2024Bank of AmericaDowngradeNeutral ➝ Underperform$13.50
12/22/2023Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$14.00 ➝ $16.00
12/8/2023Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$13.00 ➝ $14.00
11/13/2023Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$16.00 ➝ $13.00
11/7/2023Morgan StanleyLower TargetUnderweight ➝ Underweight$12.00 ➝ $11.00
10/16/2023Morgan StanleyBoost TargetUnderweight ➝ Underweight$11.00 ➝ $12.00
10/3/2023WedbushInitiated CoverageNeutral$14.00
9/27/2023Wolfe ResearchInitiated CoveragePeer Perform
9/22/2023Truist FinancialReiterated RatingHold ➝ Hold$16.00
8/25/2023Morgan StanleyLower TargetUnderweight ➝ Underweight$12.00 ➝ $11.00
7/14/2023CitigroupLower TargetNeutral$16.50 ➝ $15.00
7/12/2023Wells Fargo & CompanyBoost Target$14.50 ➝ $15.00
7/5/2023BarclaysLower Target$16.00 ➝ $15.00
6/27/2023Morgan StanleyLower Target$13.00 ➝ $12.00
4/27/2023Stifel NicolausBoost Target$15.25 ➝ $15.50
4/26/2023BarclaysLower Target$18.00 ➝ $16.00
4/13/2023Truist FinancialLower TargetHold$18.00 ➝ $16.00
3/30/2023Wells Fargo & CompanyLower TargetEqual Weight$17.00 ➝ $14.00
3/27/2023Stifel NicolausLower Target$16.50 ➝ $15.25
2/7/2023Morgan StanleyLower TargetUnderweight$13.00 ➝ $12.00
2/2/2023Wells Fargo & CompanyLower TargetEqual Weight$18.00 ➝ $17.00
2/1/2023CitigroupBoost TargetNeutral$15.00 ➝ $16.50
1/18/2023Morgan StanleyLower TargetUnderweight$15.00 ➝ $13.00
12/21/2022BarclaysLower TargetEqual Weight$22.00 ➝ $18.00
12/9/2022Raymond JamesDowngradeOutperform ➝ Market Perform
12/5/2022Morgan StanleyInitiated CoverageUnderweight$15.00
12/2/2022BMO Capital MarketsDowngradeOutperform ➝ Market Perform$20.00 ➝ $18.00
11/1/2022Compass PointLower Target$28.00
11/1/2022Raymond JamesLower TargetOutperform$24.00 ➝ $22.00
10/20/2022Truist FinancialLower TargetHold$24.00 ➝ $18.00
9/23/2022Stifel NicolausLower Target$23.50 ➝ $19.00
8/29/2022Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$26.00 ➝ $20.00
8/9/2022CitigroupBoost Target$21.00
7/11/2022Evercore ISIReiterated RatingUnderperform$19.00
7/7/2022BarclaysLower TargetEqual Weight$26.00 ➝ $22.00
6/24/2022Stifel NicolausLower Target$26.25 ➝ $23.25
3/23/2022Sumitomo Mitsui Financial GroupInitiated CoverageOutperform$27.00
1/10/2022UBS GroupDowngradeNeutral
1/10/2022Bank of AmericaDowngradeBuy ➝ Neutral$26.00 ➝ $24.00
1/10/2022Raymond JamesUpgradeMarket Perform ➝ Outperform$27.00
1/7/2022BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$25.00 ➝ $26.00
10/6/2021CitigroupLower TargetNeutral$26.00 ➝ $25.00
9/10/2021Robert W. BairdReiterated RatingHold$26.00
3/12/2021BTIG ResearchBoost TargetBuy$23.00 ➝ $27.00
3/1/2021Compass PointUpgradeNeutral ➝ Buy$23.50 ➝ $26.00
12/15/2020Smith Barney CitigroupUpgradeSell ➝ Neutral
12/10/2020Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$17.50 ➝ $22.00
11/16/2020Wells Fargo & CompanyBoost TargetEqual Weight$13.00 ➝ $17.50
10/5/2020Compass PointInitiated CoverageNeutral$14.50
9/29/2020Bank of AmericaUpgradeNeutral ➝ Buy$12.50 ➝ $15.00
9/21/2020CitigroupBoost TargetSell$8.50 ➝ $11.50
7/22/2020Wells Fargo & CompanyLower TargetEqual Weight$19.00 ➝ $11.50
6/22/2020BarclaysUpgradeUnderweight ➝ Equal Weight$9.00 ➝ $15.00
6/12/2020Royal Bank of CanadaLower TargetOutperform$34.00 ➝ $18.00
6/8/2020Evercore ISIDowngradeIn-Line ➝ Underperform$18.00
6/1/2020Stifel NicolausBoost TargetHold$11.00 ➝ $13.00
5/18/2020SunTrust BanksLower TargetHold$10.00 ➝ $9.00
4/29/2020SunTrust BanksLower TargetHold$23.00 ➝ $10.00
4/29/2020Stifel NicolausBoost TargetHold$9.50 ➝ $11.00
4/24/2020BTIG ResearchUpgradeNeutral ➝ Buy$16.00
4/7/2020CitigroupDowngradeNeutral ➝ Sell$25.00 ➝ $8.50
3/18/2020BarclaysReiterated RatingSell$9.00
3/16/2020Stifel NicolausDowngradeBuy ➝ Hold$20.00 ➝ $9.50
3/9/2020Wells Fargo & CompanyLower Target$25.00 ➝ $17.00
2/25/2020BarclaysLower TargetUnderweight$26.00 ➝ $24.00
1/13/2020Capital One FinancialDowngradeOverweight ➝ Equal Weight$30.00
1/7/2020Raymond JamesDowngradeOutperform ➝ Market Perform$30.00
(Data available from 11/21/2019 forward)

News Sentiment Rating

0.97 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 7 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/24/2024
  • 8 very positive mentions
  • 5 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
5/24/2024
  • 8 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/23/2024
  • 8 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/23/2024
  • 18 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/22/2024
  • 12 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/21/2024
  • 14 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/21/2024
  • 17 very positive mentions
  • 7 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
11/20/2024

Current Sentiment

  • 17 very positive mentions
  • 7 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Pebblebrook Hotel Trust logo
Pebblebrook Hotel Trust (NYSE: PEB) is a publicly traded real estate investment trust ("REIT") and the largest owner of urban and resort lifestyle hotels and resorts in the United States. The Company owns 47 hotels and resorts, totaling approximately 12,200 guest rooms across 13 urban and resort markets.
Read More

Today's Range

Now: $12.55
Low: $12.50
High: $12.66

50 Day Range

MA: $12.84
Low: $11.85
High: $14.30

52 Week Range

Now: $12.55
Low: $11.65
High: $16.65

Volume

114,407 shs

Average Volume

1,670,563 shs

Market Capitalization

$1.50 billion

P/E Ratio

N/A

Dividend Yield

0.32%

Beta

1.85

Frequently Asked Questions

What sell-side analysts currently cover shares of Pebblebrook Hotel Trust?

The following Wall Street research analysts have issued stock ratings on Pebblebrook Hotel Trust in the last twelve months: Bank of America Co., Compass Point, Robert W. Baird, StockNews.com, Truist Financial Co., and Wells Fargo & Company.
View the latest analyst ratings for PEB.

What is the current price target for Pebblebrook Hotel Trust?

0 Wall Street analysts have set twelve-month price targets for Pebblebrook Hotel Trust in the last year. Their average twelve-month price target is $14.30, suggesting a possible upside of 15.6%. Compass Point has the highest price target set, predicting PEB will reach $17.00 in the next twelve months. Wells Fargo & Company has the lowest price target set, forecasting a price of $13.00 for Pebblebrook Hotel Trust in the next year.
View the latest price targets for PEB.

What is the current consensus analyst rating for Pebblebrook Hotel Trust?

Pebblebrook Hotel Trust currently has 1 sell rating and 4 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Reduce."
View the latest ratings for PEB.

What other companies compete with Pebblebrook Hotel Trust?

Other companies that are similar to Pebblebrook Hotel Trust include Rayonier, Sabra Health Care REIT, The GEO Group, National Health Investors and EPR Properties. Learn More about companies similar to Pebblebrook Hotel Trust.

How do I contact Pebblebrook Hotel Trust's investor relations team?

Pebblebrook Hotel Trust's physical mailing address is 4747 BETHESDA AVENUE SUITE 1100, BETHESDA MD, 20814. The real estate investment trust's listed phone number is (240) 507-1300. The official website for Pebblebrook Hotel Trust is www.pebblebrookhotels.com. Learn More about contacing Pebblebrook Hotel Trust investor relations.